17-44377095-G-C

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4BA1BP7

This summary comes from the ClinGen Evidence Repository: After a comprehensive literature search of the intronic variant NM_000419.5(ITGA2B):c.2188-7C>G, no individuals with Glanzmann Thrombasthenia were reported with the variant. The variant has a high minor allele frequency of 0.4311 (6420/14892 alleles) in the East Asian population, which is higher than the ClinGen PD VCEP threshold (>0.0024), and therefore meets benign criterion (BA1). In silico predictor spliceAI revealed that the intronic mutation is not expected to impact splicing and a PhyloP score of 0.287 shows that the nucleotide position is not highly conserved (BP4, BP7). In summary, this variant meets the criteria to be classified as Benign for autosomal recessive Glanzmann Thrombasthenia based on the ACMG/AMP criteria applied, as specified by the ClinGen PD VCEP: BA1, BP4 and BP7 (PD VCEP specifications version 2.1). LINK:https://erepo.genome.network/evrepo/ui/classification/CA8602787/MONDO:0100326/011

Frequency

Genomes: 𝑓 0.39 ( 11438 hom., cov: 31)
Exomes 𝑓: 0.38 ( 100831 hom. )

Consequence

ITGA2B
NM_000419.5 splice_region, intron

Scores

2
Splicing: ADA: 0.005056
2

Clinical Significance

Benign reviewed by expert panel B:7

Conservation

PhyloP100: 0.709
Variant links:
Genes affected
ITGA2B (HGNC:6138): (integrin subunit alpha 2b) This gene encodes a member of the integrin alpha chain family of proteins. The encoded preproprotein is proteolytically processed to generate light and heavy chains that associate through disulfide linkages to form a subunit of the alpha-IIb/beta-3 integrin cell adhesion receptor. This receptor plays a crucial role in the blood coagulation system, by mediating platelet aggregation. Mutations in this gene are associated with platelet-type bleeding disorders, which are characterized by a failure of platelet aggregation, including Glanzmann thrombasthenia. [provided by RefSeq, Jan 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
For more information check the summary or visit ClinGen Evidence Repository.
BP7
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ITGA2BNM_000419.5 linkc.2188-7C>G splice_region_variant, intron_variant Intron 21 of 29 ENST00000262407.6 NP_000410.2 P08514-1
ITGA2BXM_011524749.2 linkc.2341-7C>G splice_region_variant, intron_variant Intron 21 of 28 XP_011523051.2 P08514
ITGA2BXM_011524750.2 linkc.2341-7C>G splice_region_variant, intron_variant Intron 21 of 28 XP_011523052.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ITGA2BENST00000262407.6 linkc.2188-7C>G splice_region_variant, intron_variant Intron 21 of 29 1 NM_000419.5 ENSP00000262407.5 P08514-1
ITGA2BENST00000648408.1 linkc.1618-7C>G splice_region_variant, intron_variant Intron 17 of 24 ENSP00000498119.1 A0A3B3IU79
ITGA2BENST00000592462.5 linkn.983-7C>G splice_region_variant, intron_variant Intron 10 of 14 5

Frequencies

GnomAD3 genomes
AF:
0.387
AC:
58804
AN:
151814
Hom.:
11444
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.388
Gnomad AMI
AF:
0.412
Gnomad AMR
AF:
0.349
Gnomad ASJ
AF:
0.437
Gnomad EAS
AF:
0.446
Gnomad SAS
AF:
0.353
Gnomad FIN
AF:
0.436
Gnomad MID
AF:
0.320
Gnomad NFE
AF:
0.384
Gnomad OTH
AF:
0.362
GnomAD2 exomes
AF:
0.386
AC:
67631
AN:
175214
AF XY:
0.382
show subpopulations
Gnomad AFR exome
AF:
0.385
Gnomad AMR exome
AF:
0.376
Gnomad ASJ exome
AF:
0.422
Gnomad EAS exome
AF:
0.431
Gnomad FIN exome
AF:
0.438
Gnomad NFE exome
AF:
0.381
Gnomad OTH exome
AF:
0.364
GnomAD4 exome
AF:
0.377
AC:
530527
AN:
1407284
Hom.:
100831
Cov.:
33
AF XY:
0.375
AC XY:
261025
AN XY:
695440
show subpopulations
Gnomad4 AFR exome
AF:
0.367
AC:
11928
AN:
32462
Gnomad4 AMR exome
AF:
0.370
AC:
13775
AN:
37250
Gnomad4 ASJ exome
AF:
0.425
AC:
10717
AN:
25190
Gnomad4 EAS exome
AF:
0.426
AC:
15925
AN:
37360
Gnomad4 SAS exome
AF:
0.346
AC:
27693
AN:
80130
Gnomad4 FIN exome
AF:
0.430
AC:
21002
AN:
48790
Gnomad4 NFE exome
AF:
0.375
AC:
405289
AN:
1081948
Gnomad4 Remaining exome
AF:
0.380
AC:
22194
AN:
58448
Heterozygous variant carriers
0
15729
31458
47186
62915
78644
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
12908
25816
38724
51632
64540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.387
AC:
58819
AN:
151932
Hom.:
11438
Cov.:
31
AF XY:
0.387
AC XY:
28704
AN XY:
74230
show subpopulations
Gnomad4 AFR
AF:
0.388
AC:
0.387861
AN:
0.387861
Gnomad4 AMR
AF:
0.349
AC:
0.348865
AN:
0.348865
Gnomad4 ASJ
AF:
0.437
AC:
0.436636
AN:
0.436636
Gnomad4 EAS
AF:
0.445
AC:
0.445068
AN:
0.445068
Gnomad4 SAS
AF:
0.351
AC:
0.350728
AN:
0.350728
Gnomad4 FIN
AF:
0.436
AC:
0.435524
AN:
0.435524
Gnomad4 NFE
AF:
0.384
AC:
0.384255
AN:
0.384255
Gnomad4 OTH
AF:
0.358
AC:
0.358428
AN:
0.358428
Heterozygous variant carriers
0
1838
3676
5514
7352
9190
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
570
1140
1710
2280
2850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.388
Hom.:
2648
Bravo
AF:
0.380
Asia WGS
AF:
0.401
AC:
1403
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

Glanzmann thrombasthenia Benign:3
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Sep 07, 2023
ClinGen Platelet Disorders Variant Curation Expert Panel, ClinGen
Significance:Benign
Review Status:reviewed by expert panel
Collection Method:curation

After a comprehensive literature search of the intronic variant NM_000419.5(ITGA2B):c.2188-7C>G, no individuals with Glanzmann Thrombasthenia were reported with the variant. The variant has a high minor allele frequency of 0.4311 (6420/14892 alleles) in the East Asian population, which is higher than the ClinGen PD VCEP threshold (>0.0024), and therefore meets benign criterion (BA1). In silico predictor spliceAI revealed that the intronic mutation is not expected to impact splicing and a PhyloP score of 0.287 shows that the nucleotide position is not highly conserved (BP4, BP7). In summary, this variant meets the criteria to be classified as Benign for autosomal recessive Glanzmann Thrombasthenia based on the ACMG/AMP criteria applied, as specified by the ClinGen PD VCEP: BA1, BP4 and BP7 (PD VCEP specifications version 2.1). -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Glanzmann thrombasthenia 1 Benign:1
Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
2.5
DANN
Benign
0.53
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0051
dbscSNV1_RF
Benign
0.13
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs850730; hg19: chr17-42454463; COSMIC: COSV52231019; COSMIC: COSV52231019; API